MSB 2.67% 96.0¢ mesoblast limited

Ann: COVID ARDS Trial Respiratory Outcomes Presented, page-65

  1. 12,514 Posts.
    lightbulb Created with Sketch. 3391
    Thanks @LearningEachDay and @stockrock, you guys are bringing some sanity back to these threads - hey, the sky is not falling after all!

    What frustrate me more than anything is the sense of urgency is lost to the FDA.
    Sure, the urgency was there for Vaccines - and that get applied to lot more people - where is the LT study of side-effects etc... that's ok, on balance it's better to have the Vaccine to protect the population

    But, for a treatment that shows promises, the FDA is willing to take it nice and slow, to follow due process - hello FDA!!!
    We are still in the midst of a pandemic - there are simply too many people dying mad.png
    ... and where is NIH - they seen enough data at Mt Sinai and acted; but, now we have much more data and they are not re-acting???

    Something is very wrong here in the land of the FDA - no wonder the Acting FDA Commissioner Woodcock is pushing for an external review!

    I'm looking forward to EUA - but, c'mon move it along FDA!!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.0¢
Change
0.025(2.67%)
Mkt cap ! $1.096B
Open High Low Value Volume
95.0¢ 96.5¢ 94.0¢ $1.231M 1.291M

Buyers (Bids)

No. Vol. Price($)
4 94461 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
96.0¢ 61151 6
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.